TipRanks
Advertisement
Advertisement
Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial
PremiumCompany AnnouncementsTiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial
16d ago
Tiziana Life Sciences announces last patient completed Phase 2a INFORM-MS trial
Premium
The Fly
Tiziana Life Sciences announces last patient completed Phase 2a INFORM-MS trial
16d ago
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
Premium
Company Announcements
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
20d ago
Tiziana Life Sciences CEO Ivor Elrifi purchases 321,423 shares
PremiumThe FlyTiziana Life Sciences CEO Ivor Elrifi purchases 321,423 shares
2M ago
Tiziana Life Sciences CEO Increases Stake with Nasdaq Share Purchase
Premium
Company Announcements
Tiziana Life Sciences CEO Increases Stake with Nasdaq Share Purchase
2M ago
Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses
Premium
Company Announcements
Tiziana Life Sciences CEO Boosts Stake as Lead MS Therapy Progresses
2M ago
Tiziana Life Sciences doses last patient in intranasal foralumab trial
PremiumThe FlyTiziana Life Sciences doses last patient in intranasal foralumab trial
3M ago
Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares
Premium
The Fly
Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares
4M ago
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance
Premium
Company Announcements
Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―